Ankur Dhingra - Feb 2, 2022 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
Chief Financial Officer
Signature
/s/ Ankur Dhingra
Stock symbol
CDNA
Transactions as of
Feb 2, 2022
Transactions value $
$0
Form type
4
Date filed
2/4/2022, 04:48 PM
Previous filing
Nov 29, 2021
Next filing
Mar 28, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Award $0 +19.9K +137.24% $0.00 34.4K Feb 2, 2022 Direct F1
holding CDNA Common Stock 5K Feb 2, 2022 By Dhingra Family Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDNA Employee Stock Option (right to buy) Award $0 +34.9K $0.00 34.9K Feb 2, 2022 Common Stock 34.9K $41.32 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units, 1/4th of which shall vest on February 2, 2023 and 1/4th of which shall vest on each anniversary thereafter.
F2 1/4th of the shares subject to the option shall vest on February 2, 2023 and 1/48th of the shares subject to the option shall vest monthly thereafter.